Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VHT vs JDOC overlap: 61% of top holdings shared

Bottom line

How much do VHT and JDOC overlap?

61% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 56.1% of VHT's assets and 56.1% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

VHT holds far more positions (407 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

VHTJDOC
Weight overlap (top 25)61%
Shared holdings15
Weight in shared holdings56.1%56.1%
Total positions40761
Expense ratio0.09%0.65%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings VHT and JDOC have in common

Holding% of VHT% of JDOCOverlap
Eli Lilly & Co14.04%7.76%7.76%
Johnson & Johnson8.47%4.82%4.82%
AbbVie Inc6.09%7.85%6.09%
UnitedHealth Group Inc5.45%5.85%5.45%
Merck & Co Inc4.66%4.82%4.66%
Thermo Fisher Scientific Inc2.93%3.73%2.93%
Intuitive Surgical Inc2.38%1.93%1.93%
Abbott Laboratories2.35%3.11%2.35%
Bristol-Myers Squibb Co1.84%3.57%1.84%
Danaher Corp1.84%2.16%1.84%
CVS Health Corp1.83%2.83%1.83%
Stryker Corp1.66%2.23%1.66%
Regeneron Pharmaceuticals Inc1.00%1.60%1.00%
Edwards Lifesciences Corp0.79%1.73%0.79%
Cencora Inc0.79%2.07%0.79%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VHT

  1. Amgen Inc — 2.87%
  2. Gilead Sciences Inc — 2.64%
  3. Pfizer Inc — 2.35%
  4. Vertex Pharmaceuticals Inc — 1.80%
  5. Medtronic PLC — 1.50%
  6. McKesson Corp — 1.45%
  7. Elevance Health Inc — 1.35%
  8. Cigna Group/The — 1.17%
  9. Boston Scientific Corp — 1.13%
  10. HCA Healthcare Inc — 0.96%

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Argenx SE — 2.06%
  6. IQVIA Holdings, Inc. — 1.71%
  7. Teva Pharmaceutical Industries Ltd. — 1.60%
  8. Novartis AG — 1.60%
  9. Biogen, Inc. — 1.56%
  10. Cardinal Health, Inc. — 1.51%

Asset mix

Asset typeVHTJDOC
Stocks99.8%99.2%
Cash & short-term funds0.2%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryVHTJDOC
US100.0%75.2%
GB—6.2%
CH—4.4%
DK—4.0%
JP—2.5%
NL—2.4%
DE—1.9%
IL—1.6%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do VHT and JDOC overlap?
About 61% by weight. 15 securities appear in both funds' top 25 holdings; they make up 56.1% of VHT's assets and 56.1% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VHT and JDOC have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, UnitedHealth Group Inc, Johnson & Johnson, Merck & Co Inc.
Should I own both VHT and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VHT or JDOC?
VHT is broader, with 407 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.